Adrián Alonso Ruiz, Anna Bezruki, Erika Shinabargar, Kaitlin Large, Marcela Vieira, Iulia Slovenski, Yiqi Liu, Surabhi Agarwal, Anna Becker, Suerie Moon
BACKGROUND: Unequal and inequitable access to Covid-19 vaccines in low- and middle-income countries (L&MICs) was a major political, ethical and public health failure in the pandemic. However, vaccine developers' practices were not monolithic, but rather, took diverse approaches to supplying different countries, with important implications for global access. RESULTS: Using data on R&D investments, regulatory approvals, manufacturing and purchase agreements, and vaccine deliveries, we identified six distinct innovation models that apply across the 14 COVID-19 vaccines with more international presence from 2020-2022...
March 26, 2024: Globalization and Health